The Bone Extracellular Matrix as an Ideal Milieu for Cancer Cell Metastases

被引:58
作者
Kolb, Alexus D. [1 ]
Bussard, Karen M. [1 ]
机构
[1] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA
关键词
bone extracellular matrix; breast cancer; prostate cancer; multiple myeloma; metastasis; bone remodeling; mechanotransduction; MESENCHYMAL STEM-CELLS; BREAST-CANCER; PROSTATE-CANCER; LUNG-CANCER; TGF-BETA; OSTEOCLAST DIFFERENTIATION; SKELETAL COMPLICATIONS; IN-VITRO; MECHANICAL-PROPERTIES; ZOLEDRONIC ACID;
D O I
10.3390/cancers11071020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bone is a preferential site for cancer metastases, including multiple myeloma, prostate, and breast cancers.The composition of bone, especially the extracellular matrix (ECM), make it an attractive site for cancer cell colonization and survival. The bone ECM is composed of living cells embedded within a matrix composed of both organic and inorganic components. Among the organic components, type I collagen provides the tensile strength of bone. Inorganic components, including hydroxyapatite crystals, are an integral component of bone and provide bone with its rigidity. Under normal circumstances, two of the main cell types in bone, the osteoblasts and osteoclasts, help to maintain bone homeostasis and remodeling through cellular communication and response to biophysical signals from the ECM. However, under pathological conditions, including osteoporosis and cancer, bone remodeling is dysregulated. Once in the bone matrix, disseminated tumor cells utilize normal products of bone remodeling, such as collagen type I, to fuel cancer cell proliferation and lesion outgrowth. Models to study the complex interactions between the bone matrix and metastatic cancer cells are limited. Advances in understanding the interactions between the bone ECM and bone metastatic cancer cells are necessary in order to both regulate and prevent metastatic cancer cell growth in bone.
引用
收藏
页数:27
相关论文
共 231 条
  • [1] Alberts B, 2015, MOLECULAR BIOLOGY OF THE CELL, SIXTH EDITION, P1
  • [2] Extracellular matrix networks in bone remodeling
    Alford, Andrea I.
    Kozloff, Kenneth M.
    Hankenson, Kurt D.
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2015, 65 : 20 - 31
  • [3] Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma
    Alsayed, Yazan
    Ngo, Hai
    Runnels, Judith
    Leleu, Xavier
    Singha, Ujjal K.
    Pitsillides, Costas M.
    Spencer, Joel A.
    Kimlinger, Teresa
    Ghobrial, Joanna M.
    Jia, Xiaoying
    Lu, Ganwei
    Timm, Michael
    Kumar, Ashok
    Cote, Daniel
    Veilleux, Israel
    Hedin, Karen E.
    Roodman, G. David
    WitZig, Thomas E.
    Kung, Andrew L.
    Hideshima, Teru
    Anderson, Kenneth C.
    Lin, Charles P.
    Ghobrial, Irene M.
    [J]. BLOOD, 2007, 109 (07) : 2708 - 2717
  • [4] Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts
    Azuma, Y
    Kaji, K
    Katogi, R
    Takeshita, S
    Kudo, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (07) : 4858 - 4864
  • [5] Protein kinase D3 modulates MMP1 and MMP13 expression in human chondrocytes
    Baker, Jonathan
    Falconer, Adrian M. D.
    Wilkinson, David J.
    Europe-Finner, G. Nicholas
    Litherland, Gary J.
    Rowan, Andrew D.
    [J]. PLOS ONE, 2018, 13 (04):
  • [6] The rationale for targeting the LOX family in cancer
    Barker, Holly E.
    Cox, Thomas R.
    Erler, Janine T.
    [J]. NATURE REVIEWS CANCER, 2012, 12 (08) : 540 - 552
  • [7] Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial
    Barrett-Lee, Peter
    Casbard, Angela
    Abraham, Jacinta
    Hood, Kerenza
    Coleman, Robert
    Simmonds, Peter
    Timmins, Hayley
    Wheatley, Duncan
    Grieve, Robert
    Griffithst, Gareth
    Murray, Nick
    [J]. LANCET ONCOLOGY, 2014, 15 (01) : 114 - 122
  • [8] Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro
    Benford, HL
    McGowan, NWA
    Helfrich, MH
    Nuttall, ME
    Rogers, MJ
    [J]. BONE, 2001, 28 (05) : 465 - 473
  • [9] RELEVANCE OF OSTEOCLAST-SPECIFIC ENZYME ACTIVITIES IN CELL-BASED IN VITRO RESORPTION ASSAYS
    Bernhardt, A.
    Koperski, K.
    Schumacher, M.
    Gelinsky, M.
    [J]. EUROPEAN CELLS & MATERIALS, 2017, 33 : 28 - 42
  • [10] Biskup E., 2017, SWISS MED WEEKLY, V147